Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bartenstein

Showing results (341-350 of 546) with videos related to

Pageof 55
Sort By:
Human Brain Mapping|November 12, 2009
Human dopamine receptor D2/D3 availability predicts amygdala reactivity to unpleasant stimuliAndrea Kobiella, Sabine Vollstädt-Klein, Mira Bühler, et al.
Brain Structure & Function|October 2, 2014
Sequential [(18)F]FDG µPET whole-brain imaging of central vestibular compensation: a model of deafferentation-induced brain plasticityAndreas Zwergal, Julia Schlichtiger, Guoming Xiong, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 5, 2011
FET-PET for malignant glioma treatment planningMaximilian Niyazi, Julia Geisler, Axel Siefert, et al.
Cell Transplantation|November 7, 2012
Decompression of inflammatory edema along with endothelial cell therapy expedites regeneration after renal ischemia-reperfusion injuryTanja Herrler, Hao Wang, Anne Tischer, et al.
Addiction Biology|October 26, 2011
[18F]Fallypride PET measurement of striatal and extrastriatal dopamine D 2/3 receptor availability in recently abstinent alcoholicsAxel Rominger, Paul Cumming, Guoming Xiong, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 13, 2022
Prognostic value of the International Metabolic Prognostic Index for lymphoma patients receiving chimeric antigen receptor T-cell therapyMichael Winkelmann, Viktoria Blumenberg, Kai Rejeski, et al.
Neuroimage|September 24, 2013
Impact of partial volume effect correction on cerebral β-amyloid imaging in APP-Swe mice using [(18)F]-florbetaben PETMatthias Brendel, Andreas Delker, Christina Rötzer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 16, 2014
In vivo mesenchymal stem cell tracking with PET using the dopamine type 2 receptor and 18F-fallyprideVeronika Schönitzer, Florian Haasters, Stefanie Käsbauer, et al.
European Journal of Cancer (Oxford, England : 1990)|March 5, 2016
Effectiveness and side-effects of peptide receptor radionuclide therapy for neuroendocrine neoplasms in Germany: A multi-institutional registry study with prospective follow-upDieter Hörsch, Samer Ezziddin, Alexander Haug, et al.
Hepatobiliary Surgery and Nutrition|June 9, 2020
Radioembolization for neuroendocrine liver metastases is safe and effective prior to major hepatic resectionFlorian Bösch, Harun Ilhan, Vanessa Pfahler, et al.
Pageof 55

Showing results (341-350 of 546) with videos related to

Sort By:
Pageof 55
Human Brain Mapping|November 12, 2009
Human dopamine receptor D2/D3 availability predicts amygdala reactivity to unpleasant stimuliAndrea Kobiella, Sabine Vollstädt-Klein, Mira Bühler, et al.
Brain Structure & Function|October 2, 2014
Sequential [(18)F]FDG µPET whole-brain imaging of central vestibular compensation: a model of deafferentation-induced brain plasticityAndreas Zwergal, Julia Schlichtiger, Guoming Xiong, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 5, 2011
FET-PET for malignant glioma treatment planningMaximilian Niyazi, Julia Geisler, Axel Siefert, et al.
Cell Transplantation|November 7, 2012
Decompression of inflammatory edema along with endothelial cell therapy expedites regeneration after renal ischemia-reperfusion injuryTanja Herrler, Hao Wang, Anne Tischer, et al.
Addiction Biology|October 26, 2011
[18F]Fallypride PET measurement of striatal and extrastriatal dopamine D 2/3 receptor availability in recently abstinent alcoholicsAxel Rominger, Paul Cumming, Guoming Xiong, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 13, 2022
Prognostic value of the International Metabolic Prognostic Index for lymphoma patients receiving chimeric antigen receptor T-cell therapyMichael Winkelmann, Viktoria Blumenberg, Kai Rejeski, et al.
Neuroimage|September 24, 2013
Impact of partial volume effect correction on cerebral β-amyloid imaging in APP-Swe mice using [(18)F]-florbetaben PETMatthias Brendel, Andreas Delker, Christina Rötzer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 16, 2014
In vivo mesenchymal stem cell tracking with PET using the dopamine type 2 receptor and 18F-fallyprideVeronika Schönitzer, Florian Haasters, Stefanie Käsbauer, et al.
European Journal of Cancer (Oxford, England : 1990)|March 5, 2016
Effectiveness and side-effects of peptide receptor radionuclide therapy for neuroendocrine neoplasms in Germany: A multi-institutional registry study with prospective follow-upDieter Hörsch, Samer Ezziddin, Alexander Haug, et al.
Hepatobiliary Surgery and Nutrition|June 9, 2020
Radioembolization for neuroendocrine liver metastases is safe and effective prior to major hepatic resectionFlorian Bösch, Harun Ilhan, Vanessa Pfahler, et al.
Pageof 55